J.P. Morgan Private Wealth Advisors LLC Acquires 463 Shares of Waters Co. (NYSE:WAT)

J.P. Morgan Private Wealth Advisors LLC raised its holdings in Waters Co. (NYSE:WATFree Report) by 14.7% during the third quarter, HoldingsChannel reports. The firm owned 3,608 shares of the medical instruments supplier’s stock after acquiring an additional 463 shares during the quarter. J.P. Morgan Private Wealth Advisors LLC’s holdings in Waters were worth $989,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Oppenheimer & Co. Inc. boosted its holdings in shares of Waters by 57.5% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 4,415 shares of the medical instruments supplier’s stock valued at $1,211,000 after acquiring an additional 1,611 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in shares of Waters during the 3rd quarter valued at $1,089,000. Robeco Schweiz AG boosted its holdings in shares of Waters by 14.7% during the 3rd quarter. Robeco Schweiz AG now owns 315,225 shares of the medical instruments supplier’s stock valued at $86,438,000 after acquiring an additional 40,342 shares in the last quarter. Findlay Park Partners LLP acquired a new stake in shares of Waters during the 3rd quarter valued at $78,017,000. Finally, New York State Common Retirement Fund boosted its holdings in shares of Waters by 0.9% during the 3rd quarter. New York State Common Retirement Fund now owns 214,252 shares of the medical instruments supplier’s stock valued at $58,750,000 after acquiring an additional 1,991 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

WAT stock opened at $320.20 on Tuesday. The stock has a 50-day moving average price of $315.76 and a 200-day moving average price of $285.57. Waters Co. has a 1-year low of $231.90 and a 1-year high of $341.94. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 2.71. The firm has a market cap of $18.93 billion, a PE ratio of 29.51, a price-to-earnings-growth ratio of 6.42 and a beta of 0.92.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.06. Waters had a return on equity of 81.30% and a net margin of 21.72%. The firm had revenue of $819.50 million during the quarter, compared to analyst estimates of $815.50 million. During the same period last year, the company posted $3.84 EPS. The business’s quarterly revenue was down 4.5% on a year-over-year basis. As a group, equities research analysts expect that Waters Co. will post 11.89 earnings per share for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of several recent research reports. Citigroup raised their price objective on Waters from $265.00 to $300.00 and gave the company a “neutral” rating in a report on Monday, December 11th. Stifel Nicolaus raised their target price on Waters from $290.00 to $330.00 and gave the stock a “hold” rating in a research report on Wednesday, February 7th. Wells Fargo & Company lowered their target price on Waters from $305.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 8th. Wolfe Research started coverage on Waters in a research report on Wednesday, December 13th. They set a “peer perform” rating for the company. Finally, JPMorgan Chase & Co. lowered their target price on Waters from $260.00 to $250.00 and set a “neutral” rating for the company in a research report on Wednesday, November 8th. One research analyst has rated the stock with a sell rating and eight have issued a hold rating to the company. According to data from MarketBeat.com, Waters presently has a consensus rating of “Hold” and an average price target of $293.50.

Get Our Latest Stock Analysis on WAT

About Waters

(Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.